Aion Therapeutic Price To Book vs. Return On Asset

ANTCF Stock  USD 0  0.01  65.83%   
Based on the measurements of profitability obtained from Aion Therapeutic's financial statements, Aion Therapeutic may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Aion Therapeutic's ability to earn profits and add value for shareholders.
For Aion Therapeutic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aion Therapeutic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aion Therapeutic utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aion Therapeutic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aion Therapeutic over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Aion Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aion Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aion Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aion Therapeutic Return On Asset vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Aion Therapeutic's current stock value. Our valuation model uses many indicators to compare Aion Therapeutic value to that of its competitors to determine the firm's financial worth.
Aion Therapeutic is rated fourth in price to book category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aion Therapeutic's earnings, one of the primary drivers of an investment's value.

Aion Return On Asset vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Aion Therapeutic

P/B

 = 

MV Per Share

BV Per Share

 = 
5.77 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Aion Therapeutic

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.96
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Aion Return On Asset Comparison

Aion Therapeutic is currently under evaluation in return on asset category among its peers.

Aion Therapeutic Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Aion Therapeutic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aion Therapeutic will eventually generate negative long term returns. The profitability progress is the general direction of Aion Therapeutic's change in net profit over the period of time. It can combine multiple indicators of Aion Therapeutic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.

Aion Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Aion Therapeutic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aion Therapeutic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aion Therapeutic's important profitability drivers and their relationship over time.

Use Aion Therapeutic in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aion Therapeutic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will appreciate offsetting losses from the drop in the long position's value.

Aion Therapeutic Pair Trading

Aion Therapeutic Pair Trading Analysis

The ability to find closely correlated positions to Aion Therapeutic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aion Therapeutic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aion Therapeutic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aion Therapeutic to buy it.
The correlation of Aion Therapeutic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aion Therapeutic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aion Therapeutic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aion Therapeutic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Aion Therapeutic position

In addition to having Aion Therapeutic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Government Funds Thematic Idea Now

Government Funds
Government Funds Theme
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Aion Pink Sheet

To fully project Aion Therapeutic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aion Therapeutic at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aion Therapeutic's income statement, its balance sheet, and the statement of cash flows.
Potential Aion Therapeutic investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Aion Therapeutic investors may work on each financial statement separately, they are all related. The changes in Aion Therapeutic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aion Therapeutic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.